The role of TNF/TNFR in organ-specific and systemic autoimmunity: implications for the design of optimized 'anti-TNF' therapies.
Kollias
George
G
Institute for Immunology, Biomedical Sciences Research Centre, Alexander Fleming, Vari, Greece. giorgos_kollias@hol.gr
Kontoyiannis
Dimitris
D
Douni
Eleni
E
Kassiotis
George
G
D020816:Amino Acid Motifs; D000818:Animals; D001327:Autoimmune Diseases / Q000276:immunology / Q000378:metabolism; D015551:Autoimmunity / Q000276:immunology*; D015195:Drug Design; D020022:Genetic Predisposition to Disease; D006801:Humans; D007108:Immune Tolerance; D008180:Lupus Erythematosus, Systemic / Q000276:immunology / Q000378:metabolism; D051379:Mice; D008815:Mice, Inbred Strains; D018345:Mice, Knockout; D008817:Mice, Mutant Strains; D023421:Models, Animal; D009928:Organ Specificity; D018124:Receptors, Tumor Necrosis Factor / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000145:classification / Q000502:physiology*; D015398:Signal Transduction; D013601:T-Lymphocytes / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000172:deficiency / Q000502:physiology*
D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha